Amanda Hammer - May 1, 2023 Form 4 Insider Report for MANGOCEUTICALS, INC. (MGRX)

Role: Chief Operating Officer
Signature: /s/ Amanda Hammer
Stock symbol: MGRX
Transactions as of: May 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/4/2023, 10:42 AM
Next filing: Jun 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGRX	Common Stock	Award	$0	+75K		$0.00	75K	May 1, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGRX	Stock Option (Right to Buy)	Award	$0	+150K		$0.00	150K	May 1, 2023	Common Stock	150K	$1.10	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Issued as a sign-on bonus for agreeing to become the Chief Operating Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.
F2	The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan in consideration for services to be rendered as Chief Operating Officer. Granted under the registrant's 2022 Equity Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.
F3	The options vest at the rate of 1/3rd of such options on each of May 1, 2024, 2025 and 2026, subject to the Reporting Person's continued service to the Company on such vesting dates.